孕期表观遗传年龄与儿童期ADHD症状:前瞻性多队列研究
该研究在三个大型出生队列中,利用脐带血DNA甲基化计算多种孕期表观遗传时钟的年龄加速(EAA),并荟萃分析其与5-7岁ADHD症状的关联(n=3383)。结果显示临床测量及表观遗传估计的孕龄较低均与ADHD症状负相关,但校正临床孕龄后的残余EAA与ADHD症状无关。
要点
- 临床孕龄及Bohlin、EPIC重叠表观遗传孕龄较低与5-7岁ADHD症状增多相关。
- 校正临床孕龄后的残余EAA与ADHD症状无关联,不提供独立风险信息。
- Knight表观遗传时钟孕龄与ADHD症状的关联无统计学意义。
核心结论
- 较低的孕龄(临床测量或表观遗传估计)与儿童期ADHD症状增多相关,但表观遗传年龄加速不独立于临床孕龄提供ADHD风险信息。
研究设计与样本
- 前瞻性多队列研究,纳入Generation R、ALSPAC和MoBa三个出生队列,基于脐带血DNA甲基化计算Bohlin、EPIC重叠和Knight孕期表观遗传时钟,荟萃分析n=3383。
主要发现
- 临床孕龄与ADHD症状负相关(β=-0.04,p<0.001)。
- Bohlin表观遗传孕龄与ADHD症状负相关(β=-0.05,p=0.01)。
- EPIC重叠表观遗传孕龄与ADHD症状负相关(β=-0.05,p=0.01)。
- Knight表观遗传孕龄与ADHD症状关联无统计学意义(β=-0.01,p=0.26)。
- 校正临床孕龄后的残余EAA与ADHD症状无关联。
关键数值与推荐
- 临床孕龄与ADHD症状关联:β=-0.04,p<0.001。
- Bohlin表观遗传孕龄与ADHD症状关联:β=-0.05,p=0.01。
- EPIC重叠表观遗传孕龄与ADHD症状关联:β=-0.05,p=0.01。
- Knight表观遗传孕龄与ADHD症状关联:β=-0.01,p=0.26。
临床怎么用
- 临床评估儿童ADHD风险时,出生孕龄是重要参考因素,表观遗传年龄加速不增加独立预测价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Epigenetic age acceleration (EAA), defined as the difference between chronological age and epigenetically predicted age, was calculated from multiple gestational epigenetic clocks (Bohlin, EPIC overlap, and Knight) using DNA methylation levels from cord blood in three large population-based birth cohorts: the Generation R Study (The Netherlands), the Avon Longitudinal Study of Parents and Children (United Kingdom), and the Norwegian Mother, Father and Child Cohort Study (Norway). We hypothesized that a lower EAA associates prospectively with increased ADHD symptoms. We tested our hypotheses in these three cohorts and meta-analyzed the results (n = 3383). We replicated previous research on the association between gestational age (GA) and ADHD. Both clinically measured gestational age as well as epigenetic age measures at birth were negatively associated with ADHD symptoms at ages 5-7 years (clinical GA: β = -0.04, p < 0.001, Bohlin: β = -0.05, p = 0.01; EPIC overlap: β = -0.05, p = 0.01; Knight: β = -0.01, p = 0.26). Raw EAA (difference between clinical and epigenetically estimated gestational age) was positively associated with ADHD in our main model, whereas residual EAA (raw EAA corrected for clinical gestational age) was not associated with ADHD symptoms across cohorts. Overall, findings support a link between lower gestational age (either measured clinically or using epigenetic-derived estimates) and ADHD symptoms. Epigenetic age acceleration does not, however, add unique information about ADHD risk independent of clinically estimated gestational age at birth.
引用
- Salontaji K, Haftorn KL, Sanders F, et al. Gestational epigenetic age and ADHD symptoms in childhood: a prospective, multi-cohort study. Mol Psychiatry. 2024. PMID: 38561466. doi:10.1038/s41380-024-02544-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。